<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Jivdhara - Innovative Healthcare Solutions</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <link rel="stylesheet" href="index.css">
    <link rel="stylesheet" href="style.css">
      
</head>
<body>
    <!-- Header & Navigation -->
    <header>
        <div class="container">
            <nav>
                <a href="#" class="logo">
                 <span>Jivdhara</span>
                </a>
                <ul class="nav-links">
                    <li><a href="index.html">Home</a></li>
                  
                    <li><a href="Products.html">Products</a></li>
                    <li><a href="R&D.html">R&D</a></li>
                  
                    <li><a href="#contact">Contact</a></li>
                </ul>
                <div class="mobile-menu">
                    <i class="fas fa-bars"></i>
                </div>
            </nav>
        </div>
    </header>

    <!-- Hero Section -->
    <section class="hero" id="home">
        <div class="container hero-content animate fade-in">
            <h1>Research & Development</h1>
            <p>Dedicated to improving global health through groundbreaking research, high-quality medicines, and affordable healthcare solutions.</p>
           
        </div>
    </section>

   
    

    

    <!-- R&D Section -->
    <section class="section" id="rnd" style="background-color: #f5f7fa;">
        <div class="container">
            <div class="section-title animate fade-in delay-1">
                <h2>Research & Development</h2>
                <p>Our commitment to innovation drives the discovery of novel therapeutics to address unmet medical needs.</p>
            </div>
            <div class="about-content">
                <div class="about-image animate slide-in-left delay-2">
                    <img src="photos/Research.png" alt="Scientists conducting pharmaceutical research in high-tech laboratory setting" />
                </div>
                <div class="about-text animate slide-in-right delay-2">
                    <h3>Innovating for Tomorrow's Health</h3>
                    <p>At Jivdhara, we invest significantly in R&D to discover and develop innovative medicines. Our research spans multiple areas including oncology, cardiology, anti-allergy, and infectious diseases.</p>
                    <p>Our global team of scientists and researchers work tirelessly to translate scientific discoveries into medicines that improve patients' lives. We collaborate with academic institutions, biotech companies, and healthcare providers worldwide.</p>
                  
                    </ul>
                   
                </div>
            </div>
        </div>
    </section>
    <div class="dashboard">
            <div class="dashboard-controls">
                <div class="search-box">
                    <i>üîç</i>
                    <input type="text" id="searchInput" placeholder="Search projects...">
                </div>
                
            </div>

            <div class="loading">
                <div>Loading data...</div>
            </div>

            <div class="table-responsive">
                <table id="rdTable">
                    <thead>
                        <tr>
                            <th>No.</th>
                            <th>Therapeutic Category</th>
                            <th>Disease Indication</th>
                            <th>Product</th>
                            <th>Strength</th>
                            <th>Dosage Form</th>
                            <th>Innovator Company</th>
                            <th>Innovator Brand</th>
                            <th>Detailed Contents</th>
                        </tr>
                    </thead>
                    <tbody id="tableBody">
                        <!-- Table content will be populated via JavaScript -->
                    </tbody>
                </table>
            </div>

            <div class="pagination">
                <button id="prevPage">Previous</button>
                <span id="pageInfo">Page 1 of 5</span>
                <button id="nextPage">Next</button>
            </div>
        </div>
    </div>

    <!-- Project Details Modal -->
    <div class="modal" id="projectModal">
        <div class="modal-content">
            <div class="modal-header">
                <h2 id="modalTitle">Project Details</h2>
                <button class="close-btn" id="closeModal">&times;</button>
            </div>
            <div id="modalContent">
                <p>Loading project details...</p>
            </div>
        </div>
    </div>
  

    <!-- Contact Section -->
    <section class="section contact" id="contact">
        <div class="container">
            <div class="section-title animate fade-in delay-1">
                <h2>Contact Us</h2>
                <p>We'd love to hear from you. Get in touch with our team for any inquiries or partnerships.</p>
            </div>
            <div class="contact-content">
                <div class="contact-info animate slide-in-left delay-2">
                    <h3>Corporate Headquarters</h3>
                    <div class="contact-item">
                        <i class="fas fa-map-marker-alt"></i>
                        <div class="contact-text">
                            <h4>Address</h4>
                            <p>504, Shiv Angan Complex, Sallaiya, 
     Bhopal Madhya Pradesh, 
     India</p>
                        </div>
                    </div>
                    <div class="contact-item">
                        <i class="fas fa-phone"></i>
                        <div class="contact-text">
                            <h4>Phone</h4>
                            <p><a href="tel:+91-755-2467262">+91-755-2467262</a></p>
                        </div>
                    </div>
                    <div class="contact-item">
                        <i class="fas fa-envelope"></i>
                        <div class="contact-text">
                            <h4>Email</h4>
                            <p><a href="office@jivdhara.in">office@jivdhara.in</a></p>
                        </div>
                    </div>
                    <div class="contact-item">
                        <i class="fas fa-clock"></i>
                        <div class="contact-text">
                            <h4>Business Hours</h4>
                            <p>Monday - Friday: 8:00 AM - 5:00 PM IST</p>
                        </div>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="container">
            <div class="footer-content animate fade-in delay-1">
                <div class="footer-column">
                    <h3>Jivdhara Pharma</h3>
                    <p>Innovating for a healthier world. Committed to discovering, developing, and delivering innovative medicines that make a difference.</p>
                    <div class="social-links">
                        <a href="#"><i class="fab fa-facebook-f"></i></a>
                        <a href="#"><i class="fab fa-twitter"></i></a>
                        <a href="#"><i class="fab fa-linkedin-in"></i></a>
                        <a href="#"><i class="fab fa-instagram"></i></a>
                        <a href="#"><i class="fab fa-youtube"></i></a>
                    </div>
                </div>
                <div class="footer-column">
                    <h3>Quick Links</h3>
                    <ul class="footer-links">
                        <li><a href="index.html">Home</a></li>
                        
                        <li><a href="Products.html">Products</a></li>
                        <li><a href="R&D.html">Research</a></li>
                       
                        <li><a href="#contact">Contact</a></li>
                    </ul>
                </div>
               
                
           
            <div class="copyright animate fade-in delay-2">
                <p>&copy; 2021 Jivdhara Pharmaceuticals. All Rights Reserved.</p>
            </div>
        </div>
    </footer>

   
    <script>
        document.addEventListener('DOMContentLoaded', function() {
            // Mobile Menu Toggle
            const mobileMenuBtn = document.querySelector('.mobile-menu');
            const navLinks = document.querySelector('.nav-links');
            
            mobileMenuBtn.addEventListener('click', function() {
                navLinks.classList.toggle('active');
                this.innerHTML = navLinks.classList.contains('active') ? 
                    '<i class="fas fa-times"></i>' : '<i class="fas fa-bars"></i>';
            });

            // Smooth Scrolling for Anchor Links
            document.querySelectorAll('a[href^="#"]').forEach(anchor => {
                anchor.addEventListener('click', function(e) {
                    e.preventDefault();
                    
                    if(navLinks.classList.contains('active')) {
                        navLinks.classList.remove('active');
                        mobileMenuBtn.innerHTML = '<i class="fas fa-bars"></i>';
                    }

                    const targetId = this.getAttribute('href');
                    if(targetId === '#') return;
                    
                    const targetElement = document.querySelector(targetId);
                    if(targetElement) {
                        window.scrollTo({
                            top: targetElement.offsetTop - 80,
                            behavior: 'smooth'
                        });
                    }
                });
            });

            // Header Scroll Effect
            const header = document.querySelector('header');
            window.addEventListener('scroll', function() {
                if(window.scrollY > 50) {
                    header.classList.add('scrolled');
                } else {
                    header.classList.remove('scrolled');
                }
            });

            // Intersection Observer for Animations
            const animateElements = document.querySelectorAll('.animate');
            
            const observer = new IntersectionObserver((entries) => {
                entries.forEach(entry => {
                    if(entry.isIntersecting) {
                        entry.target.classList.add(entry.target.dataset.animation);
                    }
                });
            }, {
                threshold: 0.1
            });

            animateElements.forEach(element => {
                const animationType = Array.from(element.classList)
                    .find(cls => cls.startsWith('slide-in') || cls === 'fade-in');
                
                if(animationType) {
                    element.dataset.animation = animationType;
                    observer.observe(element);
                }
            });

            // Product Card Hover Animation
            const productCards = document.querySelectorAll('.product-card');
            productCards.forEach(card => {
                card.addEventListener('mouseenter', function() {
                    this.style.transform = 'translateY(-10px)';
                });
                card.addEventListener('mouseleave', function() {
                    this.style.transform = 'translateY(0)';
                });
            });

            // Contact Form Submission
            const contactForm = document.getElementById('contactForm');
            if(contactForm) {
                contactForm.addEventListener('submit', function(e) {
                    e.preventDefault();
                    alert('Thank you for your message! We will get back to you soon.');
                    this.reset();
                });
            }

            // Scroll to top button
            const scrollToTopBtn = document.createElement('button');
            scrollToTopBtn.innerHTML = '<i class="fas fa-arrow-up"></i>';
            scrollToTopBtn.className = 'scroll-to-top';
            scrollToTopBtn.style.display = 'none';
            scrollToTopBtn.style.position = 'fixed';
            scrollToTopBtn.style.bottom = '30px';
            scrollToTopBtn.style.right = '30px';
            scrollToTopBtn.style.width = '50px';
            scrollToTopBtn.style.height = '50px';
            scrollToTopBtn.style.borderRadius = '50%';
            scrollToTopBtn.style.backgroundColor = 'var(--primary)';
            scrollToTopBtn.style.color = 'white';
            scrollToTopBtn.style.border = 'none';
            scrollToTopBtn.style.cursor = 'pointer';
            scrollToTopBtn.style.transition = 'all 0.3s ease';
            scrollToTopBtn.style.boxShadow = '0 5px 15px rgba(0,0,0,0.1)';
            scrollToTopBtn.style.fontSize = '1.2rem';
            scrollToTopBtn.style.zIndex = '999';
            
            scrollToTopBtn.addEventListener('mouseenter', function() {
                this.style.backgroundColor = 'var(--secondary)';
                this.style.transform = 'scale(1.1)';
            });
            
            scrollToTopBtn.addEventListener('mouseleave', function() {
                this.style.backgroundColor = 'var(--primary)';
                this.style.transform = 'scale(1)';
            });
            
            scrollToTopBtn.addEventListener('click', function() {
                window.scrollTo({
                    top: 0,
                    behavior: 'smooth'
                });
            });
            
            document.body.appendChild(scrollToTopBtn);
            
            window.addEventListener('scroll', function() {
                if(window.scrollY > 300) {
                    scrollToTopBtn.style.display = 'flex';
                    scrollToTopBtn.style.justifyContent = 'center';
                    scrollToTopBtn.style.alignItems = 'center';
                } else {
                    scrollToTopBtn.style.display = 'none';
                }
            });
        });
        // Sample R&D data (50 projects)
        
        const departments = ['Biotech', 'AI & ML', 'Clean Energy', 'Advanced Materials'];
        const statuses = ['planning', 'active', 'completed', 'hold'];
        const firstNames = ['Alex', 'Jamie', 'Taylor', 'Morgan', 'Jordan', 'Casey', 'Riley', 'Quinn', 'Peyton', 'Dakota'];
        const lastNames = ['Smith', 'Johnson', 'Williams', 'Brown', 'Jones', 'Miller', 'Davis', 'Garcia', 'Wilson', 'Anderson'];
        const milestones = [
            'Concept Approved',
            'Prototype Development',
            'Phase 1 Testing',
            'Regulatory Review',
            'Market Analysis',
            'Patent Filed',
            'Commercialization Plan',
            'Phase 2 Testing',
            'Pilot Production',
            'Final Review'
        ];

   
       const rdProjects = [
  {
    id: 1,
    therapeuticCategory: "Anticoagulant (Factor Xa Inhibitor)",
    diseaseIndication: "Stroke prevention in non-valvular atrial fibrillation, treatment/prevention of DVT/PE",
    product: "Apixaban",
    strength: "2.5 mg, 5 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Bristol Myers Squibb/Pfizer",
    innovatorBrand: "Eliquis",
    detailedContents: "Oral, direct factor Xa inhibitor, no antidote required, generic versions launched in 2025"
  },
  {
    id: 2,
    therapeuticCategory: "Antiplatelet (P2Y12 Inhibitor)",
    diseaseIndication: "Acute coronary syndrome, prevention of thrombotic events",
    product: "Ticagrelor",
    strength: "60 mg, 90 mg",
    dosageForm: "Tablet",
    innovatorCompany: "AstraZeneca",
    innovatorBrand: "Brilinta/Brilique",
    detailedContents: "Oral, reversible P2Y12 inhibitor, rapid onset, generic competition in 2025"
  },
  {
    id: 3,
    therapeuticCategory: "SGLT2 Inhibitor",
    diseaseIndication: "Type 2 diabetes, heart failure, CKD",
    product: "Empagliflozin",
    strength: "10 mg, 25 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Boehringer Ingelheim/Eli Lilly",
    innovatorBrand: "Jardiance",
    detailedContents: "Oral, SGLT2 inhibitor, reduces glucose reabsorption, CV/renal benefits"
  },
  {
    id: 4,
    therapeuticCategory: "SGLT2 Inhibitor",
    diseaseIndication: "Type 2 diabetes, heart failure, CKD",
    product: "Dapagliflozin",
    strength: "5 mg, 10 mg",
    dosageForm: "Tablet",
    innovatorCompany: "AstraZeneca",
    innovatorBrand: "Farxiga/Forxiga",
    detailedContents: "Oral, SGLT2 inhibitor, pediatric approval 2024, CV/renal benefits"
  },
  {
    id: 5,
    therapeuticCategory: "SGLT2 Inhibitor",
    diseaseIndication: "Type 2 diabetes, diabetic nephropathy",
    product: "Canagliflozin",
    strength: "100 mg, 300 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Janssen (J&J)",
    innovatorBrand: "Invokana",
    detailedContents: "Oral, SGLT2 inhibitor, reduces renal progression in diabetes"
  },
  {
    id: 6,
    therapeuticCategory: "GLP-1/GIP Agonist",
    diseaseIndication: "Type 2 diabetes, obesity, obstructive sleep apnea",
    product: "Tirzepatide",
    strength: "2.5 mg to 15 mg",
    dosageForm: "Injection (SC)",
    innovatorCompany: "Eli Lilly",
    innovatorBrand: "Mounjaro (diabetes), Zepbound (obesity)",
    detailedContents: "Weekly SC injection, dual GIP/GLP-1 agonist, superior A1C/weight loss vs GLP-1 alone"
  },
  {
    id: 7,
    therapeuticCategory: "GLP-1 Agonist",
    diseaseIndication: "Type 2 diabetes, obesity, CV risk reduction, MASH",
    product: "Semaglutide",
    strength: "0.25 mg to 2.4 mg (SC), 3 mg to 14 mg (oral)",
    dosageForm: "Injection (LA), Tablet",
    innovatorCompany: "Novo Nordisk",
    innovatorBrand: "Ozempic (SC), Wegovy (SC), Rybelsus (oral)",
    detailedContents: "Weekly SC injection or daily oral, GLP-1 agonist, CV and liver benefits"
  },
  {
    id: 8,
    therapeuticCategory: "SGLT2 Inhibitor + Biguanide",
    diseaseIndication: "Type 2 diabetes",
    product: "Empagliflozin/Metformin",
    strength: "5 mg/500 mg, 12.5 mg/1000 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Boehringer Ingelheim/Eli Lilly",
    innovatorBrand: "Synjardy",
    detailedContents: "Oral, combines SGLT2 inhibition and metformin for glycemic control"
  },
  {
    id: 9,
    therapeuticCategory: "SGLT2 Inhibitor + DPP4 Inhibitor",
    diseaseIndication: "Type 2 diabetes",
    product: "Empagliflozin/Linagliptin",
    strength: "10 mg/5 mg, 25 mg/5 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Boehringer Ingelheim/Eli Lilly",
    innovatorBrand: "Glyxambi",
    detailedContents: "Oral, dual mechanism for glucose lowering, SGLT2 and DPP4 inhibition"
  },
  {
    id: 10,
    therapeuticCategory: "SGLT2/DPP4/Biguanide",
    diseaseIndication: "Type 2 diabetes",
    product: "Empagliflozin/Metformin/Linagliptin",
    strength: "10 mg/500 mg/5 mg, 25 mg/1000 mg/5 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Boehringer Ingelheim/Eli Lilly",
    innovatorBrand: "Trijardy XR",
    detailedContents: "Oral, triple therapy for enhanced glycemic control in complex cases"
  },
  {
    id: 11,
    therapeuticCategory: "GLP-1/Amylin Agonist",
    diseaseIndication: "Type 2 diabetes, obesity",
    product: "Cagrilintide/Semaglutide",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC)",
    innovatorCompany: "Novo Nordisk",
    innovatorBrand: "CagriSema",
    detailedContents: "Weekly SC injection, dual GLP-1/amylin agonist, superior weight loss vs semaglutide"
  },
  {
    id: 12,
    therapeuticCategory: "GLP-1/Glucagon Agonist",
    diseaseIndication: "Type 2 diabetes, obesity",
    product: "Mazdutide",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC)",
    innovatorCompany: "Innovent Biologics",
    innovatorBrand: "Mazdutide",
    detailedContents: "Weekly SC injection, dual GLP-1/glucagon agonist, targets liver fat reduction"
  },
  {
    id: 13,
    therapeuticCategory: "Non-Steroidal MRA",
    diseaseIndication: "CKD associated with type 2 diabetes",
    product: "Finerenone",
    strength: "10 mg, 20 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Bayer",
    innovatorBrand: "Kerendia",
    detailedContents: "Oral, non-steroidal MRA, reduces albuminuria and CV risk"
  },
  {
    id: 14,
    therapeuticCategory: "MRA + SGLT2 Inhibitor",
    diseaseIndication: "CKD, type 2 diabetes",
    product: "Finerenone/Empagliflozin",
    strength: "TBD (Phase III)",
    dosageForm: "Tablet",
    innovatorCompany: "Bayer/Boehringer Ingelheim",
    innovatorBrand: "None (in development)",
    detailedContents: "Oral, combines MRA and SGLT2 for synergistic renal protection"
  },
  {
    id: 15,
    therapeuticCategory: "THR-Œ≤ Agonist",
    diseaseIndication: "MASH",
    product: "Resmetirom",
    strength: "80 mg, 100 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Madrigal Pharmaceuticals",
    innovatorBrand: "Rezdiffra",
    detailedContents: "Oral, THR-Œ≤ agonist, reduces liver fat, first approved for MASH"
  },
  {
    id: 16,
    therapeuticCategory: "HIF-PH Inhibitor",
    diseaseIndication: "Anemia in chronic kidney disease",
    product: "Vadadustat",
    strength: "150 mg, 300 mg, 450 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Akebia Therapeutics",
    innovatorBrand: "Vafseo",
    detailedContents: "Oral, HIF-PH inhibitor, stimulates erythropoiesis"
  },
  {
    id: 17,
    therapeuticCategory: "PCSK9 Inhibitor",
    diseaseIndication: "Hypercholesterolemia, CV risk reduction",
    product: "Lerodalcibep",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "LIB Therapeutics",
    innovatorBrand: "Lerodalcibep",
    detailedContents: "Monthly SC injection, PCSK9 inhibitor, reduces LDL-C"
  },
  {
    id: 18,
    therapeuticCategory: "Antisense Oligonucleotide",
    diseaseIndication: "Lipoprotein(a)-driven CV disease",
    product: "Pelacarsen",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Ionis/Novartis",
    innovatorBrand: "Pelacarsen",
    detailedContents: "Monthly SC injection, targets LPA mRNA to reduce Lp(a) levels"
  },
  {
    id: 19,
    therapeuticCategory: "GLP-1 Agonist",
    diseaseIndication: "Type 2 diabetes, obesity",
    product: "Orforglipron",
    strength: "TBD (Phase III)",
    dosageForm: "Tablet",
    innovatorCompany: "Eli Lilly",
    innovatorBrand: "Orforglipron",
    detailedContents: "Oral, non-peptide GLP-1 agonist, daily dosing, improves A1C and weight loss"
  },
  {
    id: 20,
    therapeuticCategory: "GLP-1/GIP/Glucagon Agonist",
    diseaseIndication: "Type 2 diabetes, obesity",
    product: "Retatrutide",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Eli Lilly",
    innovatorBrand: "Retatrutide",
    detailedContents: "Weekly SC injection, triple agonist, superior weight loss vs tirzepatide"
  },
  {
    id: 21,
    therapeuticCategory: "siRNA Therapy",
    diseaseIndication: "Hypercholesterolemia, CV risk reduction",
    product: "Inclisiran",
    strength: "284 mg/1.5 mL",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Novartis",
    innovatorBrand: "Leqvio",
    detailedContents: "SC injection every 6 months, siRNA targeting PCSK9, reduces LDL-C"
  },
  {
    id: 22,
    therapeuticCategory: "Endothelin Receptor Antagonist",
    diseaseIndication: "Resistant hypertension",
    product: "Aprocitentan",
    strength: "12.5 mg, 25 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Idorsia/Janssen",
    innovatorBrand: "Tryvio",
    detailedContents: "Oral, dual ERA, first new hypertension mechanism in decades"
  },
  {
    id: 23,
    therapeuticCategory: "ANGPTL3 Inhibitor",
    diseaseIndication: "HoFH",
    product: "Evinacumab",
    strength: "150 mg/mL",
    dosageForm: "Injection (IV)",
    innovatorCompany: "Regeneron",
    innovatorBrand: "Evkeeza",
    detailedContents: "IV infusion every 4 weeks, reduces LDL-C in HoFH"
  },
  {
    id: 24,
    therapeuticCategory: "Antisense Oligonucleotide (Hypertriglyceridemia)",
    diseaseIndication: "Severe hypertriglyceridemia, FCS",
    product: "Olezarsen",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC)",
    innovatorCompany: "Ionis Pharmaceuticals",
    innovatorBrand: "Olezarsen",
    detailedContents: "SC injection, monthly, targets APOC3 mRNA to reduce triglycerides"
  },
  {
    id: 25,
    therapeuticCategory: "FGF21 Analog",
    diseaseIndication: "MASH",
    product: "Efruxifermin",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Akero Therapeutics",
    innovatorBrand: "Efruxifermin",
    detailedContents: "Weekly SC injection, FGF21 analog, reduces liver fat and fibrosis"
  },
  {
    id: 26,
    therapeuticCategory: "FGF21 Analog",
    diseaseIndication: "MASH, severe hypertriglyceridemia",
    product: "Pegozafermin",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "89bio",
    innovatorBrand: "Pegozafermin",
    detailedContents: "Weekly SC injection, FGF21 analog, targets liver fat and metabolic dysfunction"
  },
  {
    id: 27,
    therapeuticCategory: "RNAi Therapy",
    diseaseIndication: "Hypertension",
    product: "Zilebesiran",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Alnylam/Roche",
    innovatorBrand: "Zilebesiran+E13IA12:H31",
    detailedContents: "SC injection every 6 months, RNAi targeting AGT, reduces blood pressure"
  },
 
  {
    id: 28,
    therapeuticCategory: "JAK Inhibitor (Autoimmune Diseases)",
    diseaseIndication: "Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis",
    product: "Tofacitinib",
    strength: "5 mg, 10 mg, 11 mg (XR)",
    dosageForm: "Tablet, Extended-Release",
    innovatorCompany: "Pfizer",
    innovatorBrand: "Xeljanz/Xeljanz XR",
    detailedContents: "Oral, selective JAK1/3 inhibitor, black box warning for CV events and malignancy"
  },
  {
    id: 29,
    therapeuticCategory: "IL-13 Inhibitor",
    diseaseIndication: "Moderate-to-severe atopic dermatitis",
    product: "Lebrikizumab",
    strength: "250 mg",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Eli Lilly/Almirall",
    innovatorBrand: "Ebglyss",
    detailedContents: "Biweekly SC injection, targets IL-13 to reduce type 2 inflammation"
  },
  {
    id: 30,
    therapeuticCategory: "C5a Receptor Antagonist",
    diseaseIndication: "ANCA-associated vasculitis",
    product: "Avacopan",
    strength: "10 mg",
    dosageForm: "Capsule",
    innovatorCompany: "ChemoCentryx/Amgen",
    innovatorBrand: "Tavneos",
    detailedContents: "Oral, C5a inhibitor, reduces inflammation in vasculitis"
  },
  {
    id: 31,
    therapeuticCategory: "Antisense Oligonucleotide",
    diseaseIndication: "Hereditary angioedema (HAE) prophylaxis",
    product: "Donidalorsen",
    strength: "TBD (Phase III)",
    dosageForm: "Injection (SC, LA)",
    innovatorCompany: "Ionis Pharmaceuticals",
    innovatorBrand: "Donidalorsen",
    detailedContents: "Monthly SC injection, reduces prekallikrein, 62% reduction in HAE attack rates"
  },
  {
    id: 32,
    therapeuticCategory: "Plasma Kallikrein Inhibitor",
    diseaseIndication: "On-demand treatment of HAE attacks",
    product: "Sebetralstat",
    strength: "TBD (Phase III)",
    dosageForm: "Tablet",
    innovatorCompany: "KalVista Pharmaceuticals",
    innovatorBrand: "Ekterly",
    detailedContents: "Oral, first oral on-demand HAE therapy, rapid symptom relief"
  },
 
    {
        id: 33,
        therapeuticCategory: "Anti-Amyloid Therapy",
        diseaseIndication: "Early Alzheimer‚Äôs disease",
        product: "Donanemab",
        strength: "350 mg/20 mL",
        dosageForm: "Injection (IV)",
        innovatorCompany: "Eli Lilly",
        innovatorBrand: "Kisunla",
        detailedContents: "IV infusion every 4 weeks, targets amyloid-beta plaques to slow cognitive decline"
    },
    {
        id: 34,
        therapeuticCategory: "Muscarinic Agonist",
        diseaseIndication: "Schizophrenia",
        product: "Cobenfy (KarXT)",
        strength: "50 mg/20 mg (xanomeline/trospium)",
        dosageForm: "Capsule",
        innovatorCompany: "Bristol Myers Squibb (via Karuna)",
        innovatorBrand: "Cobenfy",
        detailedContents: "Oral, muscarinic M1/M4 agonist, novel non-dopamine mechanism for psychosis"
    },
    {
        id: 35,
        therapeuticCategory: "Muscarinic Agonist",
        diseaseIndication: "Schizophrenia",
        product: "Xanomeline/Trospium (KarXT)",
        strength: "50 mg/20 mg",
        dosageForm: "Capsule",
        innovatorCompany: "Bristol Myers Squibb (via Karuna)",
        innovatorBrand: "Cobenfy",
        detailedContents: "Oral, muscarinic M1/M4 agonist, novel non-dopamine mechanism for psychosis"
    },
    {
        id: 36,
        therapeuticCategory: "Nrf2 Activator",
        diseaseIndication: "Friedreich‚Äôs ataxia",
        product: "Omaveloxolone",
        strength: "50 mg",
        dosageForm: "Capsule",
        innovatorCompany: "Reata Pharmaceuticals",
        innovatorBrand: "Skyclarys",
        detailedContents: "Oral, first approved therapy for Friedreich‚Äôs ataxia, activates Nrf2 pathway"
    },
    {
        id: 37,
        therapeuticCategory: "Antisense Oligonucleotide",
        diseaseIndication: "SOD1-ALS",
        product: "Tofersen",
        strength: "100 mg/15 mL",
        dosageForm: "Injection (Intrathecal, LA)",
        innovatorCompany: "Biogen",
        innovatorBrand: "Qalsody",
        detailedContents: "Intrathecal injection every 4 weeks, targets SOD1 mRNA for ALS"
    },
    {
        id: 38,
        therapeuticCategory: "CGRP Receptor Antagonist",
        diseaseIndication: "Migraine prevention",
        product: "Atogepant",
        strength: "10 mg, 30 mg, 60 mg",
        dosageForm: "Tablet",
        innovatorCompany: "AbbVie",
        innovatorBrand: "Qulipta",
        detailedContents: "Oral, small-molecule CGRP antagonist, daily dosing for migraine prophylaxis"
    },
    {
        id: 39,
        therapeuticCategory: "Mitochondrial Therapy",
        diseaseIndication: "Primary mitochondrial myopathy, Barth syndrome",
        product: "Elamipretide",
        strength: "TBD (Phase III)",
        dosageForm: "Injection (SC, LA)",
        innovatorCompany: "Stealth BioTherapeutics",
        innovatorBrand: "Elamipretide",
        detailedContents: "Daily SC injection, targets mitochondrial dysfunction, stabilizes cardiolipin"
    },
    {
        id: 40,
        therapeuticCategory: "HIV Integrase Inhibitor",
        diseaseIndication: "HIV-1 treatment, pre-exposure prophylaxis (PrEP)",
        product: "Cabotegravir",
        strength: "200 mg/mL (IM), 30 mg (oral)",
        dosageForm: "Injection (LA), Tablet",
        innovatorCompany: "ViiV Healthcare (GSK)",
        innovatorBrand: "Apretude (inj), Vocabria (oral)",
        detailedContents: "Long-acting IM injection every 2 months for PrEP, oral lead-in option"
    },
    {
        id: 41,
        therapeuticCategory: "HIV Integrase Inhibitor",
        diseaseIndication: "HIV-1 treatment in adults and pediatrics",
        product: "Dolutegravir",
        strength: "50 mg",
        dosageForm: "Tablet",
        innovatorCompany: "ViiV Healthcare (GSK)",
        innovatorBrand: "Tivicay",
        detailedContents: "Oral, high barrier to resistance, used in combination regimens"
    },
    {
        id: 42,
        therapeuticCategory: "HIV Capsid Inhibitor",
        diseaseIndication: "HIV-1 treatment, PrEP",
        product: "Lenacapavir",
        strength: "309 mg/mL (SC), 463.5 mg (oral)",
        dosageForm: "Injection (SC, LA), Tablet",
        innovatorCompany: "Gilead Sciences",
        innovatorBrand: "Sunlenca (inj), Yeztugo (PrEP)",
        detailedContents: "SC injection every 6 months, first long-acting capsid inhibitor for HIV"
    },
    
  {
    id: 43,
    therapeuticCategory: "ALK Inhibitor",
    diseaseIndication: "ALK-positive NSCLC",
    product: "Ensartinib",
    strength: "225 mg",
    dosageForm: "Tablet",
    innovatorCompany: "Xcovery/Betta Pharmaceuticals",
    innovatorBrand: "Ensartinib",
    detailedContents: "Oral, ALK inhibitor for targeted NSCLC therapy"
  },
  {
    id: 44,
    therapeuticCategory: "VEGF/FGFR Inhibitor",
    diseaseIndication: "Advanced neuroendocrine tumors",
    product: "Surufatinib",
    strength: "250 mg",
    dosageForm: "Capsule",
    innovatorCompany: "Hutchmed",
    innovatorBrand: "Sulanda",
    detailedContents: "Oral, multi-kinase inhibitor targeting VEGF, FGFR, CSF-1R"
  },
  {
    id: 45,
    therapeuticCategory: "Antifibrotic (Tyrosine Kinase Inhibitor)",
    diseaseIndication: "Idiopathic pulmonary fibrosis, progressive fibrosing ILD",
    product: "Nintedanib",
    strength: "100 mg, 150 mg",
    dosageForm: "Capsule",
    innovatorCompany: "Boehringer Ingelheim",
    innovatorBrand: "Ofev",
    detailedContents: "Oral, multi-kinase inhibitor targeting VEGF, FGF, PDGF receptors"
  },
  {
    id: 46,
    "therapeuticCategory": "PDE3/4 Inhibitor",
    "diseaseIndication": "Chronic obstructive pulmonary disease (COPD)",
    "product": "Ensifentrine",
    "strength": "3 mg",
    "dosageForm": "Inhalation (Nebulizer)",
    "innovatorCompany": "Verona Pharma",
    "innovatorBrand": "Ohtuvayre",
    "detailedContents": "Twice-daily nebulized inhalation, dual PDE3/4 inhibitor for bronchodilation"
  },
  {
    "id": 47,
    "therapeuticCategory": "Potassium-Competitive Acid Blocker (GI)",
    "diseaseIndication": "H. pylori infection, GERD, erosive esophagitis",
    "product": "Vonoprazan",
    "strength": "10 mg, 20 mg",
    "dosageForm": "Tablet",
    "innovatorCompany": "Phathom Pharmaceuticals",
    "innovatorBrand": "Voquezna",
    "detailedContents": "Oral, P-CAB, superior acid suppression vs PPIs, co-packaged with antibiotics"
  },
  {
    "id": 48,
    "therapeuticCategory": "siRNA Therapy",
    "diseaseIndication": "Hemophilia A/B with or without inhibitors",
    "product": "Fitusiran",
    "strength": "TBD (Phase III)",
    "dosageForm": "Injection (SC, LA)",
    "innovatorCompany": "Sanofi/Alnylam",
    "innovatorBrand": "Fitusiran",
    "detailedContents": "Monthly SC injection, siRNA targeting AT3 to restore thrombin generation"
  },
  {
    "id": 49,
    "therapeuticCategory": "RNAi Therapy",
    "diseaseIndication": "Primary hyperoxaluria type 1 (PH1)",
    "product": "Nedosiran",
    "strength": "160 mg/mL",
    "dosageForm": "Injection (SC, LA)",
    "innovatorCompany": "Dicerna/Novo Nordisk",
    "innovatorBrand": "Rivfloza",
    "detailedContents": "Monthly SC injection, RNAi targeting LDHA, reduces oxalate production"
  }
]








      

   

    // DOM Elements
    const tableBody = document.getElementById('tableBody');
    const searchInput = document.getElementById('searchInput');

    const prevPageBtn = document.getElementById('prevPage');
    const nextPageBtn = document.getElementById('nextPage');
    const pageInfo = document.getElementById('pageInfo');
    const projectModal = document.getElementById('projectModal');
    const closeModal = document.getElementById('closeModal');
    const modalTitle = document.getElementById('modalTitle');
    const modalContent = document.getElementById('modalContent');

    // Pagination
    let currentPage = 1;
    const rowsPerPage = 10;
    let filteredProjects = [...rdProjects];

    // Render table
    function renderTable() {
        tableBody.innerHTML = '';
        const startIndex = (currentPage - 1) * rowsPerPage;
        const endIndex = startIndex + rowsPerPage;
        const paginatedProjects = filteredProjects.slice(startIndex, endIndex);

        paginatedProjects.forEach(project => {
            const row = document.createElement('tr');
            row.innerHTML = `
                <td>${project.id}</td>
                <td>${project.therapeuticCategory}</td>
                <td>${project.diseaseIndication}</td>
                <td>${project.product}</td>
                <td>${project.strength}</td>
                <td>${project.dosageForm}</td>
                <td>${project.innovatorCompany}</td>
                <td>${project.innovatorBrand}</td>
                <td>${project.detailedContents}</td>
            `;
            tableBody.appendChild(row);
        });

        updatePagination();
    }

    // Filter projects based on search
    function filterProjects() {
        const searchTerm = searchInput.value.toLowerCase();
        filteredProjects = rdProjects.filter(project =>
            project.therapeuticCategory.toLowerCase().includes(searchTerm) ||
            project.diseaseIndication.toLowerCase().includes(searchTerm) ||
            project.product.toLowerCase().includes(searchTerm) ||
            project.innovatorCompany.toLowerCase().includes(searchTerm) ||
            project.innovatorBrand.toLowerCase().includes(searchTerm) ||
            project.detailedContents.toLowerCase().includes(searchTerm)
        );
        currentPage = 1;
        renderTable();
    }

    // Update pagination info and button states
    function updatePagination() {
        const totalPages = Math.ceil(filteredProjects.length / rowsPerPage);
        pageInfo.textContent = `Page ${currentPage} of ${totalPages}`;
        prevPageBtn.disabled = currentPage === 1;
        nextPageBtn.disabled = currentPage === totalPages || totalPages === 0;
    }

    // View project details in modal (not used in table, but kept for future)
    function viewProjectDetails(e) {
        const projectId = parseInt(e.target.getAttribute('data-id'));
        const project = rdProjects.find(p => p.id === projectId);
        if (project) {
            modalTitle.textContent = `${project.product} - ${project.therapeuticCategory}`;
            modalContent.innerHTML = `
                <div class="project-details">
                    <p><strong>ID:</strong> ${project.id}</p>
                    <p><strong>Therapeutic Category:</strong> ${project.therapeuticCategory}</p>
                    <p><strong>Disease Indication:</strong> ${project.diseaseIndication}</p>
                    <p><strong>Product:</strong> ${project.product}</p>
                    <p><strong>Strength:</strong> ${project.strength}</p>
                    <p><strong>Dosage Form:</strong> ${project.dosageForm}</p>
                    <p><strong>Innovator Company:</strong> ${project.innovatorCompany}</p>
                    <p><strong>Brand:</strong> ${project.innovatorBrand}</p>
                    <p><strong>Details:</strong> ${project.detailedContents}</p>
                </div>
            `;
            projectModal.style.display = 'flex';
        }
    }

    // Export data to CSV
    function exportToCSV() {
        const headers = ['‚Ññ', 'Therapeutic Category', 'Disease Indication', 'Product', 'Strength', 'Dosage Form', 'Innovator Company', 'Innovator Brand', 'Detailed Contents'];
        const csvRows = [];
        csvRows.push(headers.join(','));
        filteredProjects.forEach(project => {
            const row = [
                project.id,
                `"${project.therapeuticCategory}"`,
                `"${project.diseaseIndication}"`,
                `"${project.product}"`,
                `"${project.strength}"`,
                `"${project.dosageForm}"`,
                `"${project.innovatorCompany}"`,
                `"${project.innovatorBrand}"`,
                `"${project.detailedContents}"`
            ];
            csvRows.push(row.join(','));
        });
        const csvContent = csvRows.join('\n');
        const blob = new Blob([csvContent], { type: 'text/csv' });
        const url = URL.createObjectURL(blob);
        const a = document.createElement('a');
        a.setAttribute('hidden', '');
        a.setAttribute('href', url);
        a.setAttribute('download', 'r&d_projects.csv');
        document.body.appendChild(a);
        a.click();
        document.body.removeChild(a);
    }

    // Event Listeners
    searchInput.addEventListener('input', filterProjects);
    prevPageBtn.addEventListener('click', () => {
        if (currentPage > 1) {
            currentPage--;
            renderTable();
        }
    });
    nextPageBtn.addEventListener('click', () => {
        const totalPages = Math.ceil(filteredProjects.length / rowsPerPage);
        if (currentPage < totalPages) {
            currentPage++;
            renderTable();
        }
    });
    closeModal.addEventListener('click', () => {
        projectModal.style.display = 'none';
    });
    window.addEventListener('click', (e) => {
        if (e.target === projectModal) {
            projectModal.style.display = 'none';
        }
    });

    // Initialize
    renderTable();

    </script>
</body>
</html>
